Pricing Log in Create free account

Femasys Inc. (FEMY) vs Regentis Biomaterials Ltd. (RGNT)

Femasys Inc. and Regentis Biomaterials Ltd. are both Medical Instruments & Supplies companies. Femasys Inc. is the larger, with a market value of $11.0M against $8.2M — 1.3× the size. Across the 9 metrics below, Regentis Biomaterials Ltd. leads on 7 and Femasys Inc. on 2.

Valuation

Metric FEMY RGNT Medical Instruments & Supplies median
P/E n/m — 30.28
P/S 1.93 — 2.49
P/B 1.10 n/m 2.34
Price to free cash flow n/m n/m 23.49
EV/EBITDA n/m n/m 14.87
EV/Sales 2.87 n/m 2.75
Earnings yield (347.05%) — 0.00%
Free cash flow yield (407.89%) 0.00% 0.59%

Profitability

Metric FEMY RGNT Medical Instruments & Supplies median
Gross margin 60.95% — 53.60%
Operating margin (763.90%) — 1.97%
Net margin (534.27%) — 0.00%
Free cash flow margin (786.02%) 0.00% 2.36%
Return on equity (443.65%) 0.00% 0.00%
Return on assets (94.25%) 0.00% 0.00%
Return on invested capital (176.91%) 0.00% 0.13%

Growth

Metric FEMY RGNT Medical Instruments & Supplies median
Revenue growth (TTM) 21.85% — 8.97%
EPS growth (last fiscal year) 44.71% (1,504.65%) 6.51%
Revenue growth, 5-year CAGR 17.18% — 8.85%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric FEMY RGNT Medical Instruments & Supplies median
Debt to equity 0.90 0.00 0.10
Current ratio 2.14 5.62 2.47
Net debt to EBITDA 0.23 0.89 0.97

Dividend

Metric FEMY RGNT Medical Instruments & Supplies median
Dividend yield — — 1.02%
Payout ratio — — 0.27

Size

Metric FEMY RGNT Medical Instruments & Supplies median
Market cap 10.97m 8.22m 1.71b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack